MMED analyst estimates
MiniMed (MMED) analyst ratings, the average price target and its range, and every firm's latest call.
MMED analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 13, 2026 | Redburn Partners | MiniMed initiated with a Buy at Rothschild & Co Redburn | $30.00 |
| Oct 12, 2026 | Jefferies | Jefferies Starts MiniMed Group (MMED) at Hold | $22.00 |
| Oct 8, 2026 | Mizuho Securities | MiniMed price target raised to $28 from $26 at Mizuho | $28.00 |
| Oct 6, 2026 | Barclays | MiniMed initiated with an Equal Weight at Barclays | $22.00 |
| Sep 24, 2026 | Truist Financial | MiniMed initiated with a Buy at Truist | $29.00 |
| Sep 2, 2026 | Wells Fargo | MiniMed Group (MMED) PT Raised to $28 at BofA Securities | $28.00 |
| Sep 2, 2026 | Mizuho Securities | MiniMed price target raised to $26 from $21 at Mizuho | $26.00 |
| Sep 2, 2026 | UBS | MiniMed price target raised to $28 from $25 at UBS | $28.00 |
| Sep 2, 2026 | Evercore ISI | MiniMed price target raised to $27 from $20 at Evercore ISI | $27.00 |
| Sep 2, 2026 | Deutsche Bank | MiniMed price target raised to $25 from $20 at Deutsche Bank | $25.00 |
| Sep 1, 2026 | BTIG | MiniMed Group (MMED) PT Raised to $28 at BTIG | $28.00 |
| Sep 1, 2026 | Wells Fargo | MiniMed price target raised to $26 from $22 at Wells Fargo | $26.00 |
| Jul 28, 2026 | UBS | MiniMed initiated with a Buy at UBS | $25.00 |
| Jun 4, 2026 | Wells Fargo | MiniMed price target lowered to $22 from $26 at Wells Fargo | $22.00 |
| Jun 4, 2026 | Piper Sandler | Piper Sandler on MiniMed Group (MMED): 'Nice Start as a Public Entity but Still Plenty to Prove' | $16.00 |
- 14 firms rate MMED: 11 buy, 3 hold, 0 sell.
- The average price target is $25.73 from 11 analysts, from $16.00 to $30.00.
Updated 2026-11-07 11:50 UTC